A detailed history of Tfc Financial Management transactions in Novartis Ag stock. As of the latest transaction made, Tfc Financial Management holds 264 shares of NVS stock, worth $27,405. This represents 0.0% of its overall portfolio holdings.

Number of Shares
264
Previous 63 319.05%
Holding current value
$27,405
Previous $6,000 400.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$106.13 - $120.89 $21,332 - $24,298
201 Added 319.05%
264 $30,000
Q4 2023

Jan 25, 2024

SELL
$92.27 - $101.54 $1,845 - $2,030
-20 Reduced 24.1%
63 $6,000
Q3 2023

Oct 23, 2023

BUY
$94.73 - $105.13 $1,894 - $2,102
20 Added 31.75%
83 $8,000
Q4 2022

Feb 13, 2023

SELL
$75.55 - $92.52 $11,030 - $13,507
-146 Reduced 69.86%
63 $5,000
Q2 2021

Jul 29, 2021

SELL
$85.24 - $94.15 $10,655 - $11,768
-125 Reduced 37.43%
209 $19,000
Q3 2020

Nov 12, 2020

BUY
$82.14 - $91.0 $27,434 - $30,394
334 New
334 $29,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $223B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Tfc Financial Management Portfolio

Follow Tfc Financial Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tfc Financial Management, based on Form 13F filings with the SEC.

News

Stay updated on Tfc Financial Management with notifications on news.